These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11585228)

  • 1. Variation in interpretation of the AAPM TG-43 geometry factor leads to unclearness in brachytherapy dosimetry.
    Kouwenhoven E; van der Laarse R; Schaart DR
    Med Phys; 2001 Sep; 28(9):1965-6. PubMed ID: 11585228
    [No Abstract]   [Full Text] [Related]  

  • 2. Let's abandon geometry factors other than that of a point source in brachytherapy dosimetry.
    Meli JA
    Med Phys; 2002 Aug; 29(8):1917-8; author reply 1919-20. PubMed ID: 12201439
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality assurance of treatment plans for optimized high dose rate brachytherapy--planar implants.
    Ezzell GA
    Med Phys; 1994 May; 21(5):659-61. PubMed ID: 7935200
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40.
    Kutcher GJ; Coia L; Gillin M; Hanson WF; Leibel S; Morton RJ; Palta JR; Purdy JA; Reinstein LE; Svensson GK
    Med Phys; 1994 Apr; 21(4):581-618. PubMed ID: 8058027
    [No Abstract]   [Full Text] [Related]  

  • 5. Dosimetry of 192Ir wires for LDR interstitial brachytherapy following the AAPM TG-43 dosimetric formalism.
    Karaiskos P; Papagiannis P; Angelopoulos A; Sakelliou L; Baltas D; Sandilos P; Vlachos L
    Med Phys; 2001 Feb; 28(2):156-66. PubMed ID: 11243338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo calculation of dose rate distributions around 192Ir wires.
    Ballester F; Hernández C; Pérez-Calatayud J; Lliso F
    Med Phys; 1997 Aug; 24(8):1221-8. PubMed ID: 9284243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
    Zhang P; Beddar AS; Sibata CH
    Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
    Hedtjärn H; Carlsson GA; Williamson JF
    Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
    Rivard MJ
    Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
    Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
    Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric characteristics of a linear array of gamma or beta-emitting seeds in intravascular irradiation: Monte Carlo studies for the AAPM TG-43/60 formalism.
    Ye SJ; Parsai EI; Feldmeier JJ
    Med Phys; 2003 Mar; 30(3):403-14. PubMed ID: 12674241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine.
    Nath R; Anderson LL; Meli JA; Olch AJ; Stitt JA; Williamson JF
    Med Phys; 1997 Oct; 24(10):1557-98. PubMed ID: 9350711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Monte Carlo simulation of Cf-252 dose distribution brachytherapy" [Med. Phys. 23, 707-711 (1996)].
    Wierzbicki JG; Zamenhof R
    Med Phys; 1997 Aug; 24(8):1319; author reply 1321. PubMed ID: 9284257
    [No Abstract]   [Full Text] [Related]  

  • 14. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
    Rivard MJ; Melhus CS; Kirk BL
    Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate.
    Molloy JA; Williams MB
    Med Phys; 1999 Sep; 26(9):1943-51. PubMed ID: 10505884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source.
    Karaiskos P; Angelopoulos A; Sakelliou L; Sandilos P; Antypas C; Vlachos L; Koutsouveli E
    Med Phys; 1998 Oct; 25(10):1975-84. PubMed ID: 9800706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo simulations of prostate implants to improve dosimetry and compare planning methods.
    Taschereau R; Roy J; Pouliot J
    Med Phys; 1999 Sep; 26(9):1952-9. PubMed ID: 10505885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
    Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Arm imaging for brachytherapy source reconstruction: geometrical accuracy.
    Fung AY
    Med Phys; 2002 May; 29(5):724-6. PubMed ID: 12033568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
    Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
    Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.